Dr. Ehud (Udi) Netzer joins HIL’s Board of Directors Dr. Netzer is a seasoned technology leader with over 35 years of experience covering all phases of basic research, product development, engineering, commercialization and senior management. During the past 15 years …
Continue reading »HIL and CERN announce collaboration (and Globes coverage) Novel technologies developed at CERN could be used in HIL’s system, helping to further reduce the size and cost of Proton Therapy systems and achieve HIL’s goal of making this important treatment …
Continue reading »HIL and Hebrew University announce new R&D and manufacturing facility in Jerusalem Calcalist, one of Israel’s leading financial news outlets, published HIL’s plan to set up a new R&D and manufacturing center on a 700 square-meter space leased from the …
Continue reading »HIL recognized in Israel’s Personal Medicine / Longevity industry 2019 report HIL is featured as one of 160 companies in the Aging Analytics Agency and Vetek association’s 2019 report on the Longevity Industry in Israel. The report is part of …
Continue reading »HIL CEO and Dr. Morry Blumenfeld live on TV, at OurCrowd’s Global Investor Summit HIL’s CEO Mr. Sagi Brink-Danan, and Dr. Morry Blumenfeld, Venture Partner and Chairman of the Medical Advisory Board at OurCrowd, participated in a discussion livestreamed from …
Continue reading »HIL makes cover of The Marker Bio Magazine on International Women’s Day HIL is featured in the cover story of The Marker’s Bio Magzine’s special edition for International Women’s Day. The issue is dedicated to the subject of Women’s Health, …
Continue reading »Dr. Raphaël Van Roermund joins HIL’s R&D team Dr. Van Roermund, holding a PhD in quantum physics, is an expert in proton beam transport, dose delivery systems and dosimetry. Raphael comes to HIL following 8 years at IBA, the world …
Continue reading »HIL to Participate in IIA’s China Roadshow HIL was invited to partake in Israel Innovation Authority’s (IIA) and Israeli Export Institution’s delegation to China, in affiliation with CSTEC (China Science and Technology Exchange Center). Following a multi-stage competitive process – …
Continue reading »The Nobel Prize in Physics, and an interview with HIL’s Founder & CTO Prof. Zigler This year’s Nobel Physics Prize was awarded in part to Gérard Mourou and Donna Strickland – developers of the revolutionary CPA (Chirped Pulse Amplification) technique, a …
Continue reading »Dr. Moti Botton-Dascal of the Hebrew University of Jerusalem joins HIL’s R&D team Dr. Botton-Dascal is a theoretician in plasma physics specialising in the interaction between radiation and matter. He has over 30 years’ experience in developing models and sophisticated …
Continue reading »